Streptococcus pyogenes isolated in Portugal:: Macrolide resistance phenotypes and correlation with T types

被引:32
|
作者
Melo-Cristino, J
Fernandes, ML
机构
[1] Fac Med Lisboa, Microbiol Lab, Inst Bacteriol Camara Pestana, P-1150 Lisbon, Portugal
[2] Ctr Hosp Vila Nova De Gaia, Vila Nova De Gaia, Portugal
[3] Hosp de D Estefania, Lisbon, Portugal
[4] Hosp Garcia de Orta, Almada, Portugal
[5] Hosp Santa Maria, Lisbon, Portugal
[6] Hosp Sao Joao, Porto, Portugal
[7] Hosp Santo Antonio, Porto, Portugal
[8] Hosp Sao Francisco Xavier, Lisbon, Portugal
[9] Hosp Univ Coimbra, Coimbra, Portugal
[10] Inst Nacl Saude Dr Ricardo Jorge, Delegacao Do Porto, Portugal
关键词
D O I
10.1089/mdr.1999.5.219
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
From January 1998 to June 1999, 302 clinical isolates of Streptococcus pyogenes were collected from 10 microbiology laboratories in Portugal, All strains were highly sensitive to penicillin (MIC90 = 0.012 mg/liter), The prevalence of erythromycin resistance was 35.8% and of tetracycline resistance 41.4%, The majority (79.6%) of erythromycin-resistant strains were of the MLSB constitutive resistance (CR) phenotype with high-level resistance to erythromycin (MIC90 > 256 mg/liter) and to clindamycin (MIC90 > 256 mg/liter), 16.7% showed the M phenotype with low-level erythromycin-resistance (MIC90 24 mg/liter) and susceptibility to clindamycin, and four isolates showed a phenotype characterized by low-level erythromycin resistance (MIC90 = 8 mg/liter) and high-level clindamycin resistance (MIC90 > 256 mg/liter), not previously. described. Erythromycin resistance was not associated with invasive strains. Only minor discrepancies between disk diffusion and E-test methods were observed. T serotyping was very useful for the epidemiological characterization of the strains. The most prevalent T types were T1, T4, T9, T12, T13, and T28, A statistically significant association with resistance patterns was found: T12 with erythromycin resistance MLSB CR phenotype (p < 0.001), T4 with erythromycin resistance M phenotype (p < 0.001), and T13 with tetracycline resistance (p < 0.01). Because of the high prevalence of resistance, careful surveillance of S. pyogenes isolates in Portugal is essential, routine antimicrobial susceptibility testing in clinical microbiology laboratories should be strongly encouraged, antibiotic prescription should be reviewed, and macrolides should no longer be used in the empirical therapy of acute pharyngitis.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 50 条
  • [41] Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA
    Barry, AL
    Fuchs, PC
    Brown, SD
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 139 - 140
  • [42] Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America
    Hoban, DJ
    [J]. JOURNAL OF CHEMOTHERAPY, 2002, 14 : 25 - 30
  • [43] Tetracycline and macrolide co-resistance in Streptococcus pyogenes:: Co-selection as a reason for increase in macrolide-resistant S-pyogenes?
    Nielsen, HUK
    Hammerum, AM
    Ekelund, K
    Bang, D
    Pallesen, LV
    Frimodt-Moller, N
    [J]. MICROBIAL DRUG RESISTANCE, 2004, 10 (03) : 231 - 238
  • [44] Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae
    Angot, P
    Vergnaud, M
    Auzou, M
    Leclercq, R
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (10) : 755 - 758
  • [45] Macrolide Resistance Phenotypes and Genotypes in French Clinical Isolates of Streptococcus pneumoniae
    P. Angot
    M. Vergnaud
    M. Auzou
    R. Leclercq
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 2000, 19 : 755 - 758
  • [46] Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin
    Betriu, C
    Culebras, E
    Redondo, M
    Rodríguez-Avial, I
    Gómez, M
    Boloix, A
    Picazo, JJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) : 436 - U11
  • [47] Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001
    Bergman, M
    Huikko, S
    Pihlajamäki, M
    Laippala, P
    Palva, E
    Huovinen, P
    Seppälä, H
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) : 1251 - 1256
  • [48] Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997)
    Granizo, JJ
    Aguilar, L
    Casal, J
    Dal-Ré, R
    Baquero, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 959 - 964
  • [49] Molecular Mechanisms of Tetracycline and Macrolide Resistance and emm Characterization of Streptococcus pyogenes Isolates in Tunisia
    Hraoui, Manel
    Boutiba-Ben Boubaker, Ilhem
    Doloy, Alexandra
    Ben Redjeb, Saida
    Bouvet, Anne
    [J]. MICROBIAL DRUG RESISTANCE, 2011, 17 (03) : 377 - 382
  • [50] Evolution of macrolide resistance in Streptococcus pyogenes over 14 years in an area of central Italy
    Olivieri, Raffaela
    Morandi, Matteo
    Zanchi, Alessandra
    Tordini, Giacinta
    Pozzi, Gianni
    De Luca, Andrea
    Montagnani, Francesca
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 64 : 1186 - 1195